Showing results (11-20 of 126) with videos related to
Sort By:
Pageof 13
Environmental Management|October 23, 2012
A review of the main driving factors of forest fire ignition over EuropeAnne Ganteaume, Andrea Camia, Marielle Jappiot, et al.Pharmacological Research|November 26, 2016
Deacetylase inhibitors as a novel modality in the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.Scientific Data|July 9, 2020
ERA5-based global meteorological wildfire danger mapsClaudia Vitolo, Francesca Di Giuseppe, Christopher Barnard, et al.Scientific Data|January 25, 2024
Global seasonal prediction of fire dangerFrancesca Di Giuseppe, Claudia Vitolo, Christopher Barnard, et al.Haematologica|May 10, 2007
Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significancePatricia Martín-Jiménez, Ramón García-Sanz, Ana Balanzategui, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Future directions of next-generation novel therapies, combination approaches, and the development of personalized medicine in myelomaConstantine S Mitsiades, Faith E Davies, Jacob P Laubach, et al.Clinical Lymphoma, Myeloma & Leukemia|April 16, 2024
Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual MeetingNoopur S Raje, Adam D Cohen, Krina K Patel, et al.Hematological Oncology|February 16, 2018
Carfilzomib in relapsed or refractory multiple myeloma patients with early or late relapse following prior therapy: A subgroup analysis of the randomized phase 3 ASPIRE and ENDEAVOR trialsMaria-Victoria Mateos, Hartmut Goldschmidt, Jesus San-Miguel, et al.Clinical Lymphoma, Myeloma & Leukemia|April 13, 2020
Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III StudiesMichele Cavo, Meletios A Dimopoulos, Jesus San-Miguel, et al.Blood Reviews|September 9, 2008
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myelomaAntonio Palumbo, Meletios Dimopoulos, Jesus San Miguel, et al.Pageof 13